Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pharmacogenomics and antidepression research].

Mitsuhiko Yamada1

  • 1Department of Psychiatry, Showa University Karasuyama Hospital, 6-11-11, Kitakarasuyama, Setagaya-ku, Tokyo, 157-8577 Japan.

Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology
|May 24, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

β-Arrestin-biased activation of type I angiotensin II receptors improves prognosis of murine pediatric heart failure.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Pathogenic Ca<sub>V</sub>1.1 Variants Cause Hyperpolarizing Shift of Depolarization-Induced Ca<sup>2+</sup> Release in Malignant Hyperthermia Susceptibility.

Communications biology·2026
Same author

[Non-clinical safety assessments using human cells for pediatric drug development].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2026
Same author

Immune regulation following allogeneic iPSC-derived cardiomyocyte transplantation in non-human primates.

Cardiovascular research·2025
Same author

Corrigendum to "Behavioral investigation of the sense of agency in rats by manipulating temporal delays between response and outcome: Insights from a causal reasoning task" [Behav. Brain Res. 496 (2026) 115814].

Behavioural brain research·2025
Same author

Behavioral investigation of the sense of agency in rats by manipulating temporal delays between response and outcome: Insights from a causal reasoning task.

Behavioural brain research·2025
Same journal

[Basal Ganglia Circuit Mechanisms in Cognitive Learning].

Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology·2018
Same journal

Experimental disease models for mechanistic understanding and drug discovery for psychiatric disorders.

Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology·2018
Same journal

Experience-dependent development of visual cortical functions.

Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology·2018
Same journal

The contribution of neuroplasticity induced in cholinergic neurons of the laterodorsal tegmental nucleus to cocaine addiction.

Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology·2018
Same journal

[Neuroimaging studies of depression: Current status and future direction.]

Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology·2018
Same journal

[Newly developed nomenclature (Neuroscience-based Nomenclature)].

Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology·2016
See all related articles

Pharmacogenomics identified hundreds of antidepressant-related genes (ADRGs), offering new insights into how antidepressants work. Understanding these genes and their role in neural plasticity could revolutionize depression treatment.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Genetics

Context:

  • Antidepressants have been used for over 50 years, yet their exact molecular mechanisms remain unclear.
  • Pharmacogenomics offers a method to identify genes influenced by antidepressant therapies.
  • Previous research identified hundreds of candidate antidepressant-related genes (ADRGs).

Purpose:

  • To identify genes affected by antidepressants using pharmacogenomics.
  • To understand the role of ADRGs in neural plasticity.
  • To explore novel biological targets beyond the "monoamine hypothesis" for depression.

Summary:

  • Pharmacogenomics was employed to identify hundreds of antidepressant-related genes (ADRGs).
  • These ADRGs may encode common functional molecules activated by chronic antidepressant treatment.

Related Experiment Videos

  • The study focuses on defining the roles of these molecules in drug-induced neural plasticity.

    • Impact:

    • Understanding ADRGs in neural plasticity can significantly advance research into the biological basis of antidepressants.
    • This knowledge is expected to profoundly impact depression diagnosis, prevention, and treatment strategies.
    • Novel biological approaches identified through this research may lead to paradigm shifts in antidepressant development.